{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:56:52Z","timestamp":1794315412196,"version":"4.9.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.semarthrit.2022.152153","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T11:10:49Z","timestamp":1671016249000},"page":"152153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients"],"prefix":"10.1016","volume":"58","author":[{"given":"Nuria","family":"Barroso-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Atienza-Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Ferraz-Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Prieto-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Ad\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Hern\u00e1ndez-Garfella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Mart\u00ednez-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Cordero-Coma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"D\u00edaz-Llopis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Herreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ma\u00edz-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Torre-Salaberri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"De Vicente-Delm\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"D\u00edaz-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Atanes-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santos","family":"Insua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Almod\u00f3var-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Jim\u00e9nez-Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Ruiz-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Gand\u00eda-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan M.","family":"Nolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Calvo-R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7748-853X","authenticated-orcid":false,"given":"Santos","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Gonz\u00e1lez-Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2344-2285","authenticated-orcid":false,"given":"Ricardo","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semarthrit.2022.152153_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152153_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.55563\/clinexprheumatol\/lnvc9k","article-title":"One year in review 2020: beh\u00e7et's syndrome","volume":"127","author":"Hatemi","year":"2020","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152153_bib0003","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/1744666X.2016.1205486","article-title":"Behcet's disease: epidemiology, clinical manifestations, and diagnosis","volume":"13","author":"Davatchi","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152153_bib0004","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ajo.2011.05.032","article-title":"Behcet disease: visual prognosis and factors influencing the development of visual loss","volume":"152","author":"Taylor","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152153_bib0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Beh\u00e7et disease: an analysis of 880 patients","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152153_bib0006","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.rce.2011.12.004","article-title":"Uveitis: diagnostic approach","volume":"212","author":"Mart\u00ednez-Berriotxoa","year":"2012","journal-title":"Rev Clin Esp"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152153_bib0007","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature (SUN) working group. standardization of uve\u00edtis nomenclature for reporting clinical data. results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152153_bib0008","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12016-014-8425-z","article-title":"Ocular involvement of Behcet's syndrome: a comprehensive review","volume":"49","author":"Ozyazgan","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152153_bib0009","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/112067210201200514","article-title":"Posterior segment involvement in ocular Behcet's disease","volume":"12","author":"Ozdal","year":"2002","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152153_bib0010","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2147\/OPTH.S4033","article-title":"Cystoid macular edema","volume":"2","author":"Rotsos","year":"2008","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152153_bib0011","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000081203","article-title":"Pathomechanisms of cystoid macular edema","volume":"36","author":"Bringmann","year":"2004","journal-title":"Ophthalmic Res"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152153_bib0012","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018, update of the Eular recommendations for the management of Beh\u00e7et's syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152153_bib0013","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00296-018-4193-z","article-title":"Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Beh\u00e7et's disease associated uveitis: a systematic review","volume":"39","author":"Urruticoechea-Arana","year":"2019","journal-title":"Rheumatol Int"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152153_bib0014","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.ophtha.2018.02.020","article-title":"Successful optimization of adalimumab therapy in refractory Uveitis due to Beh\u00e7et's disease","volume":"125","author":"Mart\u00edn-Varillas","year":"2018","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152153_bib0015","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jfo.2018.09.027","article-title":"Eye and Beh\u00e7et's disease","volume":"42","author":"Ksiaa","year":"2019","journal-title":"J Fr Ophtalmol"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152153_bib0016","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/s10165-011-0497-5","article-title":"A case of Beh\u00e7et's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab","volume":"22","author":"Hirano","year":"2012","journal-title":"Mod Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152153_bib0017","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.revmed.2018.02.022","article-title":"Ocular manifestations in Beh\u00e7et's disease","volume":"39","author":"Desbois","year":"2018","journal-title":"Rev Med Interne"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152153_bib0018","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10067-017-3672-z","article-title":"IL-6 blockade in the management of non-infectious uveitis","volume":"36","author":"Lopalco","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152153_bib0019","first-page":"217","article-title":"Clinical features of patients with Beh\u00e7et's uveitis","volume":"56","author":"Liu","year":"2020","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152153_bib0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/ICU.0000000000000562","article-title":"Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics","volume":"30","author":"Thomas","year":"2019","journal-title":"Curr Opin Ophtalmol"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152153_bib0021","first-page":"621","article-title":"Efficacy of monoclonal anti-tumour necrosis factor- \u03b1 antibodies in uve\u00edtis macular edema","volume":"38","author":"Tosi","year":"2020","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152153_bib0022","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/09273948.2020.1791346","article-title":"Anti-TNF- \u03b1 Therapy for refractory uveitis associated with Beh\u00e7et's syndrome and sarcoidosis: a single center study of 131 patients","volume":"30","author":"Kunimi","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152153_bib0023","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/art.41026","article-title":"Comparative study of infliximab versus adalimumab in refractory uveitis due to Beh\u00e7et's disease: national multicenter study of 177 cases","volume":"71","author":"Atienza-Mateo","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.152153_bib0024","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajo.2018.12.019","article-title":"Anti-IL6-Receptor tocilizumab in refractory and noninfectious Uveitic cystoid macular Edema: multicenter study of 25 patiens","volume":"200","author":"Vegas-Revenga","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152153_bib0025","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s00417-013-2436-y","article-title":"Tocilizumab treatment for refractory uveitis-related cystoid macular edema. Graefe's","volume":"251","author":"Ad\u00e1n","year":"2013","journal-title":"Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152153_bib0026","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/rheumatology\/kex480","article-title":"Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Beh\u00e7et's disease: multicentre retrospective study","volume":"57","author":"Atienza-Mateo","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2022.152153_bib0027","first-page":"1","article-title":"Utility of tocilizumab in autoimmune eye diseases","volume":"20","author":"Atienza-Mateo","year":"2022","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152153_bib0028","first-page":"S75","article-title":"Tocilizumab in severe and refractory non-infectious uveitis","volume":"32","author":"Papo","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152153_bib0029","first-page":"S34","article-title":"The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Beh\u00e7et's disease: results of a multicentre open-label study","volume":"34","author":"Santos-G\u00f3mez","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152153_bib0030","doi-asserted-by":"crossref","first-page":"e14668","DOI":"10.1097\/MD.0000000000014668","article-title":"Real-world evidence of treatment for relapse of noninfectious uveitis in tertiary centers in Japan: a multicenter study","volume":"98","author":"Takeuchi","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152153_bib0031","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10787-020-00697-4","article-title":"Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Beh\u00e7et's syndrome","volume":"28","author":"Silvestri","year":"2020","journal-title":"Inflammopharmacology"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152153_bib0032","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10067-018-4228-6","article-title":"Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients","volume":"38","author":"Fabiani","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152153_bib0033","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3349\/ymj.2021.62.2.177","article-title":"The effect of adalimumab in Korean patients with refractory noninfectious uveitis","volume":"62","author":"Park","year":"2021","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.semarthrit.2022.152153_bib0034","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ophtha.2021.11.013","article-title":"Anti\u2013Tumor necrosis factor \u03b1 versus tocilizumab in the treatment of refractory uveitic macular edema: a multicenter study from the French uveitis network","volume":"129","author":"Leclercq","year":"2022","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152153_bib0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.55563\/clinexprheumatol\/9ipkcs","article-title":"Tocilizumab in Beh\u00e7et's disease with refractory ocular and\/or neurological involvement: response according to different clinical phenotypes","volume":"132","author":"Atienza-Mateo","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"8697","key":"10.1016\/j.semarthrit.2022.152153_bib0036","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease. International study group for Beh\u00e7et's disease","volume":"335","author":"Weichsler","year":"1990","journal-title":"Lancet (British Ed.)"},{"key":"10.1016\/j.semarthrit.2022.152153_bib0037","series-title":"Clinical Methods: The History, Physical, and Laboratory Examinations","article-title":"Visual acuity","author":"Levenson","year":"1990"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152153_bib0038","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","article-title":"Standardization of vitreal inflammatory activity in intermediate and posterior uveitis","volume":"92","author":"Nussenblatt","year":"1985","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2022.152153_bib0039","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3389\/fphar.2020.00655","article-title":"Pharmacological strategies for the treatment of non-infectious uveitis. A minireview","volume":"11","author":"Valenzuela","year":"2020","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152153_bib0040","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/IAE.0000000000001690","article-title":"Twenty-four-month follow-up of tocilizumab therapy for refractory uveitis-related macular edema","volume":"38","author":"Mesquida","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.semarthrit.2022.152153_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102481","article-title":"Comparison of conventional immunosuppressive drugs versus anti-TNF-\u03b1 agents in non-infectious non-anterior uveitis","volume":"113","author":"Leclercq","year":"2020","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152153_bib0042","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/14712598.2019.1595578","article-title":"Expert opinion on the use of biological therapy in non-infectious uveitis","volume":"19","author":"Touhami","year":"2019","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.semarthrit.2022.152153_bib0043","unstructured":"ClinicalTrials.gov NCT02929251 randomized trial comparing efficacy of adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis (RUBI)."},{"key":"10.1016\/j.semarthrit.2022.152153_bib0044","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10067-016-3506-4","article-title":"Interleukin (IL)-1 inhibition with anakinra and canakinumab in Beh\u00e7et's disease-related uveitis: a multicenter retrospective observational study","volume":"36","author":"Fabiani","year":"2017","journal-title":"Clin Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222002049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222002049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:11:41Z","timestamp":1758733901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017222002049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":44,"alternative-id":["S0049017222002049"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152153","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152153"}}